 | Vote Rights Disclosures | | |
| | | |
| Announcement dated 18 December 2007
(published Europe-wide 18 December 2007):
Regulatory News: Notification pursuant to Article 26 Section 1 of WpHG, intended for Europe-wide publication
Massachusetts Mutual Life Insurance Company, 1295 State Street, 01111-0001 Springfield, Massachusetts, USA, advised Carl Zeiss Meditec AG, Göschwitzer Straße 51-52, 07745 Jena, Germany, on 17 December 2007 pursuant to Art. 21 Section 1 WpHG that on 13 December 2007 their share of voting rights in Carl Zeiss Meditec AG had fallen below the threshold of 3%. The percentage of voting rights amounted to 2.84% (corresponding to 2,307,537 voting rights) on this date. All these voting rights are allocated to this company pursuant to Art. 22 Section 1 sentence 1 No. 1 WpHG.
Jena, December 2007.
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
 investors@meditec.zeiss.com
ISIN: DE0005313704
 Return to the top of page
 Return to overview
Announcement dated 9 October 2007
(published Europe-wide 11 October 2007)
Regulatory News: Notification pursuant to Article 26 Section 1 of WpHG, intended for Europe-wide publication
Threadneedle Asset Management Limited, London, United Kingdom, advised Carl Zeiss Meditec AG, Goeschwitzer Straße 51-52, 07745 Jena, Germany on 9 October 2007 pursuant to § 21 para. 1 WpHG that on 5 October 2007 the share of voting stocks of the below mentioned companies in Carl Zeiss Meditec AG, went below the threshold of 3% of the total voting stocks on this date.
Threadneedle Asset Management Limited, London, United Kingdom, advised Carl Zeiss Meditec AG that on 5 October 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went below the threshold of 3% and the percentage of voting rights amounted to 2.931% (corresponding to 2,383,174 voting rights) on this date. These voting rights are in their entirety attributable to this company pursuant to § 22 para. 1 sent. 1 No. 6 WpHG.
Threadneedle Asset Management Holdings Limited, London, United Kingdom advised Carl Zeiss Meditec AG Jena, Germany, that on 5 October 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went below the threshold of 3% and the percentage of voting rights amounted to 2.931% (corresponding to 2,383,174 voting rights) on this date. These voting rights are in their entirety attributable to this company pursuant to § 22 para. 1 sent. 1 No. 6, sent. 2 and sent 3 WpHG.
Ameriprise Financial Inc., Minneapolis, USA, advised Carl Zeiss Meditec AG that on 5 October 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went below the threshold of 3% and the percentage of voting rights amounted to 2.931% (corresponding to 2,383,174 voting rights) on this date. These voting rights are in their entirety attributable to this company pursuant to § 22 para. 1 sent. 1 No. 6, sent. 2 and sent. 3 WpHG.
Ameriprise Financial Inc. is the parent company of Threadneedle Asset Management Holdings Limited which is the parent company of Threadneedle Asset Management Limited.
Jena, October 2007
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
investors@meditec.zeiss.com
ISIN: DE0005313704
To top of page
Back to overview
Notification pursuant to Section 248a AktG
The eight claims brought against the resolution on a capital increase of the General Meeting of Carl Zeiss Meditec AG of 10 March 2006 and, on the part of one complainant, also against the corresponding resolution on amending the Articles of Association, have been ended by the withdrawal of all appeals in the court of appeal (OLG [Oberlandesgericht, Higher Disctrict Court]) Jena 6 U 802/06; first instance: LG [Landgericht, District Court] Gera 3 HK 0 69/06). Thus the verdict in the first instance of Gera District Court, in which all claims were rejected, has taken legal effect.
The complainants were Leasing und Handelsservice Heinrich GmbH (intervenor: Peter Zetsche), sophen Consulting GmbH, Peter Eck, EO Investors GmbH, Dr. Ulrich Lüdemann, Milaco GmbH (intervenor: Norbert Kind), Frank Scheunert and Stefan Spütz (intervenors for all complainants: Willi Alfred Erich Matthias Kerler and Pomoschnik Rabotajet GmbH).
Beside the complainants, intervenor Norbert Kind also filed an appeal against the first-instance verdict.
At the request of complainant Milaco GmbH (authorised proxy: attorney Prof. Dr. Klaus Steiner, Heidelberg), Carl Zeiss Meditec AG (authorised proxy: Freshfields Bruckhaus Deringer, attorney Prof. Dr. Harry Schmidt, Berlin) confirmed, in the event of the withdrawal of all appeals both for the approval process and the main process, in the first and second instance, that it would not claim for costs against the complainants and intervenors and would withdraw the claims for the assessment of costs already lodged at Gera District Court.
Jena, August 2007
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
investors@meditec.zeiss.com
ISIN: DE0005313704
To top of page
Back to overview
Announcement dated 25 May 2007
(published Europe-wide 25 May 2007)
Regulatory News: Notification pursuant to Article 26 Section 1 of WpHG, intended for Europe-wide publication
OppenheimerFunds Inc., 6803 S. Tucson Way, 80112-3924 Centennial, Colorado, USA, advised us on 25 May 2007 pursuant to § 21 para. 1 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG) that on 22 May 2007 its share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went below the threshold of 3%. The percentage of voting rights in Carl Zeiss Meditec AG as held by OppenheimerFunds, Inc. now amounts to 2.82% which corresponds to a holding of 2,289,679 shares.
Jena, May 2007
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
investors@meditec.zeiss.com
ISIN: DE0005313704
To top of page
Back to overview
Announcement dated 24 April 2007
(published Europe-wide 3 May 2007)
Regulatory News: Notification pursuant to Article 26 Section 1 of WpHG, intended for Europe-wide publication
-Amendment of the notification of Carl Zeiss Meditec AG as published on 24 April 2007-
On 20 April 2007, Carl Zeiss Meditec AG, Jena, Germany, received an amendment of the notification pursuant to § 21
para. 1 German Securities Trading Act (Wertpapierhandels- gesetz, WpHG) as sent by Threadneedle Asset Management Limited, London, United Kingdom, on 5 March 2007. The following notification is an amendment of the notification of
Carl Zeiss Meditec AG pursuant to Article 26, Section 1 WpHG as published on 24 April 2007.
With this amendment, Threadneedle Asset Management Limited, London, United Kingdom, advised us that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. These voting rights are in their entirety attributable to this company pursuant to § 22 para. 1 sent. 1 No. 6 WpHG.
With this amendment, Threadneedle Asset Management Holdings Limited, London, United Kingdom advised us that on
2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. These voting rights are in their entirety attributable to this company pursuant to § 22 para. 1 sent. 1 No. 6, sent. 2 and sent 3 WpHG.
With this amendment, Ameriprise Financial Inc., Minneapolis, USA, advised us that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. These voting rights are in their entirety attributable to this company pursuant to § 22 para. 1 sent. 1 No. 6, sent. 2 and
sent. 3 WpHG.
Ameriprise Financial Inc. is the parent company of Threadneedle Asset Management Holdings Limited which is the parent company of Threadneedle Asset Management Limited.
Jena, Mai 2007
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
investors@meditec.zeiss.com
ISIN: DE0005313704
To top of page
Back to overview
Announcement dated 20 April 2007
(published Europe-wide on 24 April 2007)
Regulatory News: Notification pursuant to Article 26 Section 1 of WpHG, intended for Europe-wide publication
-Amendment of the notification by Threadneedle Asset Management Limited as received on 5 March 2007-
On 20 April 2007, Carl Zeiss Meditec AG, Jena, Germany, received an amendment of the notification pursuant to § 21 para. 1 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG) as sent by Threadneedle Asset Management Limited, London, United Kingdom, on 5 March 2007.
With this amendment, Threadneedle Asset Management Limited, London, United Kingdom, advised us that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 Sentence 1 No. 6 WpHG.
With this amendment, Threadneedle Asset Management Holdings Limited, London, United Kingdom advised us that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 sentence 1 No. 6 WpHG.
With this amendment, Ameriprise Financial Inc., Minneapolis, USA, advised us that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 sentence 1 No. 6 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG).
Ameriprise Financial Inc. is the parent company of Threadneedle Asset Management Holdings Limited which is the parent company of Threadneedle Asset Management Limited.
Jena, April 2007
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
investors@meditec.zeiss.com
ISIN: DE0005313704
To top of page
Back to overview
Dividend notification
The Annual General Meeting of Carl Zeiss Meditec AG on 9 March 2007 resolved to distribute from its net earnings for financial year 2005/2006 a dividend of € 0.14 per no-par value share on the Company’s dividend-bearing share capital of € 81,309,610.00.
The dividend shall be paid on 12 March 2007 by Clearstream Banking AG, Frankfurt am Main.
The dividend shall be paid without the deduction of capital gains tax and solidarity surcharge on the capital gains tax, since the dividend will be distributed from the Company’s tax deposit account. For German (domestic) shareholders, therefore, the dividend distributed by Carl Zeiss Meditec AG for financial year 2005/2006 is not attributable to capital income pursuant to Art. 20 (1) No. 1 German Income Tax Act (Einkommenssteuergesetz, EstG).
The central paying agent is Commerzbank AG.
Jena, March 2007
Carl Zeiss Meditec AG
The Management Board
To top of page
Back to overview
Announcement dated 5 March 2007
(published Europe-wide on 6 March 2007)
Regulatory News: Notification pursuant to Article 26 Section 1 of WpHG, intended for Europe-wide publication
Threadneedle Asset Management Limited, London, United Kingdom, advised us on 5 March 2007 pursuant to § 21 Section 1 WpHG that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 Sentence 1 No. 6 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG).
Threadneedle Investment Services, London, United Kingdom advised us on 5 March 2007 pursuant to § 21 Section 1 WpHG that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 sentence 1 No. 6 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG).
Threadneedle Asset Management Holdings Limited, London, United Kingdom advised us on 5 March 2007 pursuant to § 21 Section 1 WpHG that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 sentence 1 No. 6 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG).
Ameriprise Financial Inc., Minneapolis, USA, advised us on 5 March 2007 pursuant to § 21 Section 1 WpHG that on 2 March 2007 their share of voting rights in Carl Zeiss Meditec AG, Jena, Germany, went above the threshold of 3% and the percentage of voting rights amounted to 3.008% (corresponding to 2,445,603 voting rights) on this date. All these voting rights are allocated to this company pursuant to § 22 Section 1 sentence 1 No. 6 German Securities Trading Act (Wertpapierhandelsgesetz, WpHG).
Ameriprise Financial Inc. is the parent company of Threadneedle Asset Management Holdings Limited which is the parent company of Threadneedle Asset Management Limited and Threadneedle Investment Services Limited.
Jena, March 2007
Carl Zeiss Meditec AG
The Management Board
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
investors@meditec.zeiss.com
ISIN: DE0005313704
To top of page
Back to overview | | |
| | | |
|